Advisory fee in common stock
Company: Core Scientific
The claim, verbatim
Core Scientific issued 386,697 shares of common stock to B. Riley Securities as an advisory fee valued at $750,000
Source (primary)
Core Scientific 8-K filed 2022-08-04 (SEC EDGAR, sec_filing)
View cached copy (2026-09-13)Live source ↗
Quote: “In connection with the execution of the Notes, the Company agreed to pay B. Riley Securities, Inc. ("BRS") an advisory fee of $750,000 (the "Advisory Fee") payable in fully paid and non-assessable shares of the Company's common stock, par value $0.0001 per share (the "Common Stock")... On August 1, 2022, the Company issued 386,697 shares of Common Stock to BRS in satisfaction of the Advisory Fee.”
How we checked this
Checked on September 22, 2026. The cited source supports every part of this claim.
The document states the $750,000 advisory fee to B. Riley Securities was satisfied by issuing 386,697 shares of common stock.
Confirmed in the source:
- Core Scientific issued 386,697 shares of common stock to B. Riley Securities
- The shares were issued as an advisory fee
- The advisory fee was valued at $750,000
What we did: Read our cached copy of SEC EDGAR (https://www.sec.gov/Archives/edgar/data/1839341/000119312522212538/d373174d8k.htm) in full (7,649 characters, retrieved September 13, 2026) and checked each assertion in the claim against it.
Additional evidence
confirms Core Scientific 8-K filed 2022-08-04
Quote: “In connection with the execution of the Notes, the Company agreed to pay B. Riley Securities, Inc. ("BRS") an advisory fee of $750,000 (the "Advisory Fee") payable in fully paid and non-assessable shares of the Company's common stock, par value $0.0001 per share (the "Common Stock")... On August 1, 2022, the Company issued 386,697 shares of Common Stock to BRS in satisfaction of the Advisory Fee.”